Skip to content
Biodatica
Start free

THORMED INNOVATION LLC

DALLAS, TX

OncologyCAR-TPhase III
Compare Sign in to watch

What changed

Phase II trial registered: CEUS Evaluation of Hydrocephalus in Neonates and Infants

3w agoTrial registeredJun 25, 2026Source filing (opens the source filing in a new tab)

Momentum

79no change

Momentum 79 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

553 pre-ticker oncology companies at Phase III

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Jul 15, 2026

    Hydrocephalus in Infants, Hydrocephalus Acquired · RECRUITING · sponsor: Children's Hospital of Philadelphia · CEUS Evaluation of Hydrocephalus in Neonates and Infants

    ClinicalTrials.gov · NCT06693752 (opens the source filing in a new tab)

  2. Grant

    R01 · $499k · non-dilutive

    Jun 1, 2026

    UNIVERSITY OF TEXAS DALLAS · PI SIRSI, SHASHANK RAMESH · NIBIB · award ends Mar 31, 2030 · A New Method for Acoustic Blood Oxygen Level Dependent (BOLD) imaging

    NIH RePORTER · NIH RePORTER 11359391 (opens the source filing in a new tab)

  3. Grant

    R41 · $295k · non-dilutive

    Aug 15, 2025

    THORMED INNOVATION LLC · PI BROWN, KATHERINE GENGLER · NIBIB · award ends Aug 14, 2027 · Non Invasive Urine Output Monitor

    NIH RePORTER · NIH RePORTER 11251173 (opens the source filing in a new tab)

  4. Trial

    PHASE3 registered

    Dec 1, 2020

    Hypoxic-Ischemic Encephalopathy, Brain Ischemia Hypoxia · COMPLETED · sponsor: Children's Hospital of Philadelphia · CEUS Evaluation of Hypoxic Ischemic Injury

    ClinicalTrials.gov · NCT03549520 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources